Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

U.S. notice of patent allowance for troponin I

June 16, 1997

Banyu to shift development from NB-506 to new indolocarbazole

June 13, 1997

Paracelsian cancels launch of AndroCar

June 12, 1997

Milkhaus initiates phase II trial for prostate cancer

June 11, 1997

FDA Oncologic Drugs Advisory Committee to review three NDAs in late June

June 11, 1997

Vical's Leuvectin enters phase I/II for prostate cancer

June 11, 1997

Synthelabo and Praecis collaborate on prostate cancer product

June 10, 1997

DepoTech reacquires certain marketing rights to DepoCyt

June 9, 1997

New antitumor agent from Teikoku Hormone characterized in mice

June 9, 1997

Selective tumor targeting reported for Bexxar

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...